Related Experiment Video
Updated: May 12, 2026

07:25
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Prediction of post-PCI angina risk using machine learning-based magnetocardiography model
WenLong Wang1, LiNa Wang1, FaMing Ding1
1Department of Cardiology, Binzhou Medical University Hospital, Binzhou, Shandong, China.
Frontiers in Cardiovascular Medicine
|May 11, 2026
Summary
Magnetocardiography (MCG) effectively predicts angina risk after percutaneous coronary intervention (PCI). Combining MCG with clinical biomarkers improves risk stratification for better patient outcomes.
Area of Science:
- Cardiology
- Biomedical Engineering
- Machine Learning
Background:
- Recurrent angina post-percutaneous coronary intervention (PCI) significantly impacts patient quality of life.
- The predictive capability of noninvasive Magnetocardiography (MCG) for symptomatic outcomes after PCI is not well-defined.
Purpose of the Study:
- To develop and validate a machine learning-based MCG model for predicting angina after PCI.
- To assess the added value of combining MCG with clinical biomarkers for enhanced angina prediction.
Main Methods:
- 110 patients undergoing successful PCI were enrolled, with MCG performed pre- and post-procedure.
- Angina status was assessed using Seattle Angina Questionnaire (SAQ) domains (SAQ-AS and SAQ-AF).
- Multivariable logistic regression was used to build MCG and combined models, evaluated by AUC, sensitivity, and F1-score.
Main Results:
- The combined model integrating MCG and biomarkers showed superior discriminatory ability for angina stability (SAQ-AS).
- For angina frequency (SAQ-AF), the combined model outperformed MCG alone with higher sensitivity (0.813 vs. 0.801) and AUC (0.813 vs. 0.801).
- Nomograms provided effective risk stratification, and model calibration was satisfactory.
Conclusions:
- A machine learning-based MCG model offers an effective, noninvasive method for predicting post-PCI angina risk.
- Integrating MCG with clinical biomarkers enhances risk stratification, aiding in the identification of high-risk patients.
